Methyldigoxin is a cardiac glycoside derived from digoxin, used mainly in the treatment of congestive heart failure and certain supraventricular arrhythmias (notably atrial fibrillation). It is grouped under the following drug class(es): Glycosides. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include metildigossina and tetradecahydrocyclopenta(a)phenanthren-17-yl)-2H-furan-5-one. Its PubChem CID is 443946.
Methyldigoxin
| CAS No | 30685-43-9 |
|---|---|
| Molecular Formula | C42H66O14 |
| Molecular Weight | 795.00g/mol |
| Synonyms | 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-3-[(2R,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Methyldigoxin is a cardiac glycoside derived from digoxin, used mainly in the treatment of congestive heart failure and certain supraventricular arrhythmias (notably atrial fibrillation).
The listed CAS number is 30685-43-9.
The listed molecular formula is C42H66O14.
The listed molecular weight is 795.00g/mol.
3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-3-[(2R,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one.
The source lists metildigossina and tetradecahydrocyclopenta(a)phenanthren-17-yl)-2H-furan-5-one.